{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:06:57Z","timestamp":1790878017090,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xkme.2026.101480","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:33:34Z","timestamp":1784820814000},"page":"101480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Humoral and Cellular Immune Responses Following Bivalent SARS-CoV-2 mRNA Vaccines in Patients Undergoing Hemodialysis: A Prospective Cohort Study"],"prefix":"10.1016","volume":"8","author":[{"given":"Tsai-Chieh","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Ren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Hsuan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chang","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Hsin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1449-9431","authenticated-orcid":false,"given":"Yu-Tzu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2026.101480_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMp2215780","article-title":"Bivalent covid-19 vaccines - a cautionary tale","volume":"388","author":"Offit","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101480_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMc2213948","article-title":"Immunogenicity of BA.5 bivalent mRNA vaccine boosters","volume":"388","author":"Collier","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101480_bib4","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.vaccine.2024.04.049","article-title":"A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants","volume":"42","author":"Song","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.xkme.2026.101480_bib5","article-title":"Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis","volume":"10","author":"Cheng","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.xkme.2026.101480_bib6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra2206573","article-title":"Covid-19 vaccines - immunity, variants, boosters","volume":"387","author":"Barouch","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101480_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03445-22","article-title":"Trajectory of humoral responses to two doses of ChAdOx1 nCoV-19 vaccination in patients receiving maintenance hemodialysis","author":"Ling","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.xkme.2026.101480_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jmii.2025.08.014","article-title":"Cellular and humoral immunity following two AZD1222 and two booster vaccinations in hemodialysis patients","volume":"59","author":"Ling","year":"2026","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.xkme.2026.101480_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1002576","article-title":"Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assay","volume":"13","author":"Taffertshofer","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.xkme.2026.101480_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1023943","article-title":"Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan","volume":"13","author":"Chao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.xkme.2026.101480_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24882","article-title":"Comparative analysis between STANDARD-E Covi-FERON ELISA with pre-existing IFN-gamma release assays and determination of the optimum cutoff value for assessment of T-Cell response to SARS-CoV-2","volume":"37","author":"Jang","year":"2023","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.xkme.2026.101480_bib13","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","author":"Holm","year":"1979","journal-title":"Scand J Statist"},{"key":"10.1016\/j.xkme.2026.101480_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3233\/NRE-130893","article-title":"A less conservative method to adjust for familywise error rate in neuropsychological research: the Holm's sequential Bonferroni procedure","volume":"32","author":"Eichstaedt","year":"2013","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.xkme.2026.101480_bib15","article-title":"Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan","volume":"13","author":"Liu","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.xkme.2026.101480_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.102556","article-title":"The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan","volume":"17","author":"Tsai","year":"2024","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.xkme.2026.101480_bib17","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/cid\/ciad402","article-title":"Omicron variant-specific serological imprinting following BA.1 or BA.4\/5 bivalent vaccination and previous SARS-CoV-2 infection: a cohort study","volume":"77","author":"Baerends","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xkme.2026.101480_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/ciad209","article-title":"Immunogenicity of the BA.1 and BA.4\/BA.5 severe acute respiratory syndrome coronavirus 2 bivalent boosts: preliminary results from the COVAIL randomized clinical trial","volume":"77","author":"Branche","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xkme.2026.101480_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29303","article-title":"Live-virus serum neutralization after bivalent SARS-CoV-2 mRNA vaccination in hemodialysis patients","volume":"95","author":"Benning","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.xkme.2026.101480_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-024-00816-0","article-title":"Potent induction of humoral and cellular immunity after bivalent BA.4\/5 mRNA vaccination in dialysis patients","volume":"9","author":"Bronder","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.xkme.2026.101480_bib21","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJMc2216309","article-title":"Immunologic effect of bivalent mRNA booster in patients undergoing hemodialysis","volume":"388","author":"Huth","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101480_bib22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ekir.2023.01.020","article-title":"Immunogenicity of bivalent omicron BA.4\/5-adapted vaccine in hemodialysis patients","volume":"8","author":"Anft","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.xkme.2026.101480_bib23","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","article-title":"A bivalent omicron-containing booster vaccine against Covid-19","volume":"387","author":"Chalkias","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101480_bib24","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1038\/s41467-024-47429-8","article-title":"SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4\/5 COVID-19-vaccination in previously infected and non-infected individuals","volume":"15","author":"Urschel","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.xkme.2026.101480_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq1841","article-title":"Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure","volume":"377","author":"Reynolds","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xkme.2026.101480_bib26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1056\/NEJMc2214314","article-title":"Substantial neutralization escape by SARS-CoV-2 omicron variants BQ.1.1 and XBB.1","volume":"388","author":"Miller","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101480_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1056\/NEJMc2214293","article-title":"Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA bivalent booster","volume":"388","author":"Davis-Gardner","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101480_bib28","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1038\/s41467-023-41678-9","article-title":"Omicron variant neutralizing antibodies following BNT162b2 BA.4\/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease","volume":"14","author":"Yau","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.xkme.2026.101480_bib29","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1056\/NEJMc2302462","article-title":"Durability of bivalent boosters against omicron subvariants","volume":"388","author":"Lin","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101480_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105479","article-title":"Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice","volume":"25","author":"Gao","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.xkme.2026.101480_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1240425","article-title":"Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan","volume":"14","author":"Tani","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.xkme.2026.101480_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0006-291X(03)01389-5","article-title":"Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis","volume":"308","author":"Moser","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.xkme.2026.101480_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1084\/jem.178.2.427","article-title":"The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory","volume":"178","author":"Akbar","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.xkme.2026.101480_bib34","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2021.04.007","article-title":"Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy","volume":"99","author":"Ikizler","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101480_bib35","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 Breakthrough Infections in Vaccinated Health Care Workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xkme.2026.101480_bib36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xkme.2026.101480_bib37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526002426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526002426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:34:09Z","timestamp":1790876049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2590059526002426"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101480","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral and Cellular Immune Responses Following Bivalent SARS-CoV-2 mRNA Vaccines in Patients Undergoing Hemodialysis: A Prospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101480"}}